Position in GNTA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$24,888
New position
Shares Held
37,036
first reported quarter
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Independent Advisor Alliance holds $6,039,391 across 21 Biotechnology names. GNTA ranks #18 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,267 | $1,458,846 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
|
31,597 | $744,424 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
725 | $560,163 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,602 | $530,052 | |
| 5 | ABSI |
Absci Corp
|
153,855 | $461,565 | |
| 6 | INCY |
Incyte Corp
|
4,794 | $451,211 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
7,907 | $376,135 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
7,444 | $358,800 |
All Filings in GNTA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,888 | 37,036 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||